Cytori Therapeutics, Inc. (USA) (NASDAQ:CYTX)
| CAPS Rating |
|
|---|---|
| Open | $3.73 |
| Previous Close | $3.83 |
| Daily Range | $3.63 - $3.77 |
| 52-Week Range | $1.90 - $8.44 |
| Market Cap | $196.36M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 508,072 |
| Average Daily Volume | 0 |
CYTX
VS S&P 500 (SPY)
How do you think CYTX will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
CYTX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
CYTX News and Commentary
- Buy, Sell, or Hold: Geron – The Motley Fool
- Can Geron Recover in 2012? – The Motley Fool
- Has Geron Become the Perfect Stock? – The Motley Fool
- This Just In: More Upgrades and Downgrades – The Motley Fool
- Tomorrow's Monster Stock – The Motley Fool
- The Market Just Crushed My Stock! – The Motley Fool
- When Giving Up Is a Good Move in Biotech – The Motley Fool
- One Hot Stock to Avoid – The Motley Fool
- Whoa! What Just Happened to My Stock? – The Motley Fool
- What's All the Fuss About Stem Cells? – The Motley Fool
- Stem-Cell Stocks May Now Be Worth The Risk – SmartMoney
- 11 Health-Care Stocks Insiders Are Buying – The Motley Fool
- Cytori Heart-Attack Treatment Shows Positive Results At 18 Months – SmartMoney
- 3 Top Stocks at Half-Price – The Motley Fool
- One Stem Cell Stock to Avoid – The Motley Fool
- Cytori Therapeutics - Sales Miss? Yes ... Bad Quarter? No – SeekingAlpha
- StemCells Up for All the Right Reasons – The Motley Fool
- Cytori Therapeutics Management - Putting Its Money Where Its Mouth Is – SeekingAlpha
- Cytori: A Must Own Biotech – SeekingAlpha
- Hidden Stocks for High Returns – The Motley Fool
RSS Headlines
Fool UK
